2025-06-30 18:02 | CC:PREV | Preveceutical Medical Inc | 0.03 | News Release200 | Preveceutical appoints Tavares chief technology officer |
2025-06-25 16:28 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical to hold AGM Aug. 15 |
2025-06-11 19:01 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical arranges $750,000 private placement |
2025-06-02 16:45 | CC:PREV | Preveceutical Medical Inc | 0.04 | News Release200 | Preveceutical appoints Sampath as corporate adviser |
2025-05-30 16:50 | CC:PREV | Preveceutical Medical Inc | 0.045 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2025-05-30 16:50 | CC:PREV | Preveceutical Medical Inc | 0.045 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2025-05-26 15:53 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical appoints Glover as corporate adviser |
2025-05-22 19:35 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical closes $748,383 private placement |
2025-05-14 07:01 | CC:PREV | PreveCeutical Medical Inc. | 0.035 | News Release200 | PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies |
2025-04-30 19:12 | CC:PREV | Preveceutical Medical Inc | 0.03 | SEDAR MD & A815 | SEDAR MD & A |
2025-04-30 18:59 | CC:PREV | Preveceutical Medical Inc | 0.03 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2025-04-28 20:45 | CC:PREV | Preveceutical Medical Inc | 0.03 | News Release200 | Preveceutical Medical closes first tranche of financing |
2025-04-15 04:12 | CC:PREV | Preveceutical Medical Inc | 0.03 | News Release200 | Preveceutical further increases placement to $700,000 |
2025-04-02 19:47 | CC:PREV | Preveceutical Medical Inc | 0.025 | News Release200 | Preveceutical increases private placement to $500,000 |
2025-03-10 19:21 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical Medical extends private placement |
2025-02-06 16:06 | CC:PREV | Preveceutical Medical Inc | 0.03 | News Release200 | Preveceutical to develop N2B Sol-Gel program |
2025-02-04 17:33 | CC:PREV | Preveceutical Medical Inc | 0.025 | News Release200 | Preveceutical appoints Jones to lead Sol-Gel projects |
2025-01-24 17:42 | CC:PREV | Preveceutical Medical Inc | 0.025 | News Release200 | Preveceutical Medical arranges $300,000 unit financing |
2025-01-07 12:55 | CC:PREV | PreveCeutical Medical Inc. | 0.025 | News Release200 | BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference |
2024-12-18 19:05 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical changes auditor to Davidson & Company |
2024-12-09 16:14 | CC:PREV | Preveceutical Medical Inc | 0.025 | News Release200 | Preveceutical's BioGene appoints Lawson as director |
2024-12-05 16:26 | CC:PREV | Preveceutical Medical Inc | 0.025 | News Release200 | Preveceutical's BioGene adds Ticho to advisory board |
2024-12-04 16:19 | CC:PREV | Preveceutical Medical Inc | 0.025 | News Release200 | Preveceutical's BioGene appoints advisory board member |
2024-12-02 17:23 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical unit appoints Glover independent director |
2024-11-27 14:40 | CC:PREV | Preveceutical Medical Inc | 0.02 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-11-27 14:39 | CC:PREV | Preveceutical Medical Inc | 0.02 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-11-25 16:07 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical's BioGene appoints Sampath as director |
2024-11-21 16:43 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical's BioGene adds Dellbegovic as adviser |
2024-11-18 14:50 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical's BioGene appoints Olofsson as CSO |
2024-11-15 15:13 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical Medical closes IP asset sale to BioGene |
2024-11-13 12:22 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical appoints Georgieva as BioGene president |
2024-10-30 13:17 | CC:PREV | Preveceutical Medical Inc | | News Release200 | Preveceutical to sell IP to BioGene for $1.35M (U.S.) |
2024-10-18 16:37 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical hires Phoenix for advisory services |
2024-09-03 15:50 | CC:PREV | Preveceutical Medical Inc | 0.015 | News Release200 | Preveceutical hires Outside the Box for marketing |
2024-08-29 19:27 | CC:PREV | Preveceutical Medical Inc | 0.015 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-08-29 18:54 | CC:PREV | Preveceutical Medical Inc | 0.015 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-07-18 19:54 | CC:PREV | Preveceutical Medical Inc | 0.02 | Street Wire165 | Preveceutical's former lawyer Lotz answers lawsuit |
2024-07-09 09:22 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical Medical has MCTO revoked by BCSC |
2024-07-05 12:14 | CC:PREV | Preveceutical Medical Inc | 0.025 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-07-05 12:14 | CC:PREV | Preveceutical Medical Inc | 0.025 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |